Codon Devices Files Complaint against Febit Seeking Declaratory Judgment

Business Wire, July 12, 2007

CAMBRIDGE, Mass. -- Codon Devices, Inc., the Constructive Biology Company[TM], announced today that on June 29, 2007 it filed a complaint for a declaratory judgment against Febit Biotech GmbH, Febit Ferrarius Biotechology GmbH, and Febit, GmbH (collectively, "Febit") in the U.S. District Court for the District of Columbia.

In its complaint, Codon Devices seeks a judgment declaring that Codon Devices is not infringing U.S. Patent No. 6,586,211 (the "'211 patent"), which is purportedly owned by one of the Febit defendants, and that the '211 patent is invalid and unenforceable. In addition, Codon Devices requests an order from the Court restraining Febit from asserting the '211 patent against Codon Devices and from making representations that Codon Devices' products and services infringe the '211 patent. Further, Codon Devices seeks reimbursement for expenses in an unspecified amount.

Codon Devices also announced today that on July 9, 2007 Febit Biotech served Codon Devices with a complaint filed in the U.S. District Court for the District of Delaware alleging that Codon Devices infringes the '211 patent. Codon Devices believes the allegations are meritless.

About Codon Devices

Codon Devices, Inc., based in Cambridge, MA, is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices' proprietary synthesis and design technologies improve the productivity of its industrial, pharmaceutical and academic customers in a paradigm shift to what the Company calls Constructive Biology[TM]. The Company's focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy. Codon Devices' BioFAB[TM] platform uses sophisticated informatics, robotics and sequencing technologies to accurately synthesize genetic codes orders of magnitude more rapidly and cost-effectively than other currently available technology. More information about Codon Devices is available at www.codondevices.com.